IJCRR - 15(9), May, 2023
Pages: 08-13
Screening for Efflux Pump Mediated Resistance in Enterobacterales by Acridine Orange Agar Cartwheel Method
Author: Anusha AP, Harish Kumar KS, Rani S Jayamohan, Deepthy BJ
Category: Healthcare
[Download PDF]
Abstract:
Introduction: Aerobic gram negative bacilli such as E. coli, Klebsiella pneumoniae and Enterobacter spp are major causes of hospital-acquired infections. Efflux pump mediated resistance is one of the major mechanism contributing to antimicrobial resistance in Enterobacterales.
Aim/Objectives: The aim of our study was to detect efflux pump mediated resistance in Enterobacterales by Acridine orange agar method.
Materials and Methods: In this study, various Enterobacterales were isolated from clinical samples and identified using various biochemical tests. The screening for expression of efflux pump was done by Acridine orange agar cartwheel method.
Results: Among the Enterobacterales, E. coli showed highest prevalence of efflux pump activity followed by Klebsiella pneumoniae and Enterobacter spp.
Conclusion: In this study, it is implicated that Acridine orange can be used as an alternative to Ethidium bromide and screening for efflux pump can be done by Acridine orange agar method in a microbiology laboratory set up.
Keywords: Enterobacterales, Multidrug resistance, Extensively Drug Resistance, Efflux Pump Mediated Resistance, Acridine Orange Cartwheel Method, Antimicrobial Resistance Detection
Citation:
Anusha AP, Harish Kumar KS, Rani S Jayamohan, Deepthy BJ. Screening for Efflux Pump Mediated Resistance in Enterobacterales by Acridine Orange Agar Cartwheel Method International Journal of Current Research and Review. 15(9), May, 08-13
References:
1. Aslam B, Wang W, Arshad MI, Khurshid M, Muzammil S, Rasool MH et al. Antibiotic resistance: A rundown of a global crisis. Infect. Drug Resist. 2018, 11: 1645-58.
2. Hernando-Amado S, Coque TM, Baquero F, Marti?nez JL. Defining and combating antibiotic resistance from One Health and Global Health perspectives. Nat Microbiol. 2019, 4(9):1432– 1442.
3. Fisher RA, Gollan B, Helaine S. Persistent bacterial infections and persister cells. Nat.Rev. Microbiol. 2017, 15 :453–464.
4. Guo, Y, Song G, Sun M, Wang J, Wang Y. Prevalence and therapies of antibiotic-resistance in Staphylococcus aureus. Front. Cell. Infect. Microbiol. 2020, 10: 107.
5. Rice LB. “Progress and challenges in implementing the research on ESKAPE pathogens.” Infection Control and Hospital Epidemiology. 2010; 31(1): S7–S10.
6. GiedraitieneA, Vitkauskiene A, Naginiene R, Pavilonis A. “Antibiotic resistance mechanisms of clinically important bacteria,” Medicina (Kaunas). 2011; 47(3):137–146.
7. Wilson DN. “Ribosome-target in antibiotics and mechanisms of bacterial resistance.” Nat RevMicrobiol. 2014;12(1): 35–48.
8. Kumar A, Schweizer HP. Bacterial resistance to antibiotics: active efflux and reduced uptake. Adv Drug Deliv Rev. 2005;
57(10):1486-513.
9. Nelson ML: Modulation of antibiotic efflux in bacteria. Curr Med Chem. 2002; 1: 35-54.
10. Piddock LJ. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev. 2006;19(2): 382-402.
11. Webber MA, Piddock LJV. The importance of efflux pumps in bacterial antibiotic resistance. J Antimicrob Chemother2003; 51(1):9-11.
12. Zgurskaya HI, Nikaido H. Multidrug resistance mechanisms: drug efflux across two membranes. Mol Microb. 2000;
37(2):219-25.
13. Nikaido H. The role of outer membrane and efflux pumps in the resistance of Gram-negative bacteria. Can we improve drug access? Drug Resist Updat. 1998;1: 93-98.
14. Tenover FC. Mechanisms of antimicrobial resistance in bacteria. Am J Infect Control. 2006; 119(6 Suppl 1):S3-10; discussion S62-70.
15. Amaral L, Cerca P, Spengler G, Machado L, Martins A, Couto I et al. Ethidium bromide efflux by Salmonella: modulation by metabolic energy, pH, ions and phenothiazines. Int J Antimicrob Agents. 2011;38(2): 140-145.
16. Viveiros M, Rodrigues L, Martins M, Couto I, Spengler G, Martins A et al. Evaluation of efflux activity of bacteria by a semiautomated fluorometric system. Methods Mol Biol. 2010; 642: 159-172.
17. Paixa?o L, Rodrigues L, Couto I, Martins M, Fernandes P, de Carvalho CC et al. Fluorometric determination of ethidium bromide efflux kinetics in Escherichia coli. J Biol Eng. 2009; 3: 18.
18. M100-Performance Standards for Antimicrobial Disk Susceptibility Tests, 31th Edition. Clinical and Laboratory Standards Institute. 2021.
19. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG et al. Multidrug-resistant, extensively drugresistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012 Mar;18(3):268-81.
20. Reygaert WC. An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiol. 2018 Jun 26;4(3):482-501.
21. Sharpiro HM. Flow cytometry of bacterial membrane potential and permeability. Methods Mol Med. 2008;142:175-86.
22. Viverios M, Martins A, Rodrigues L, Martins M, Couto I. Demonstration of intrinsic efflux activity of Escherichia coli K-12
AG I00 by an automated ethidium bromide method. Int J Antimicrob Agents. 2008;31(5): 458-62.
23. Kyriacou SV, Nowak ME, Browlow WJ, Xuxhn. Single live cell imaging for real time monitoring of resistance mechanism in Pseudomonas aeruginosa. J Biomed Opt. 2002; 7(4):576-86.
24. Ramakrishna MS, Jeyamani L, Abimannan GC, Vajravelu LK. Microbial Profile and Antibiogram Pattern Analysis of Skin and Soft Tissue Infections at a Tertiary Care Center in South India. J Pure Appl Microbiol. 2021;15(2):915-925.
25. Harish Kumar KS, Asina PA,Theckel PG, Divakaran B, Sathar S, Asalatha R et al.Prevalence of multidrug resistanturopathogens isolated from different age groups in South-India: a cross-sectional study. Int J Res MedSci. 2022; 10:905-12.
26. Martins A, Amaral L. Screening for efflux pump systems of bacteria by the new acridine orange agar method. 2012 Mar-Apr; 26(2):203-6.
27. Gooyandeh S, Sahar SJ, Fatemeh N. “Evaluation of Efflux pump activity among Uropathogenic Escherichia coli and Klebsiella pneumonia multiple-Drug Resistance isolates.” International Journal of Molecular and Clinical Microbiology. 2016; 6: 708- 714.
|